BIVDA Press Releases

23Sep

Press Release - BIVDA IVD Market Audit Results Show COVID-19 Impact

BIVDA Press Release –

 

For Immediate Release

 

---

 

BIVDA IVD Market Audit Results Show COVID-19 Impact

 

  • Report shows substantial impact of COVID-19 pandemic on other diagnostic tests
  • Some diagnostic revenues down by as much as 90%
  • COVID-19 revenues skyrocket

 

The BIVDA Market Audit Report for the first half of 2020 has been published to participants. Twenty seven companies submitted revenue data which has been consolidated into a detailed report on the market size and growth, from totals down to assay level. For the first time Thermofisher Scientific have submitted data for their Microbiology products, further enhancing the coverage of the market which exceeds 95% of the total IVD market excluding Glucose self-tests.

 

The results show a substantial impact of the COVID pandemic and subsequent ‘lockdown’ period on diagnostic tests performed. Although the total market grew by 2.5%, revenues from General Chemistry, Hormones and Tumour Marker tests were reduced by 10 to 15% in the period (and this impact reflects only 3 months of ‘lockdown’ from the half year). Some test revenues were reduced by over 90%, while others increased by as much or more, and revenues from Coronavirus testing became one of the largest categories from negligible levels in 2019.

 

The BIVDA Market Audit is the most accurate and reliable source of data on the UK IVD market available by far, and participation is open to any UK IVD supplier at no cost if a member of BIVDA. Help in data submission, analysis and interpretation is available from BIVDA, and there is now also a website which allows access to data and generation of customised reports for participants.

 

For more information contact John Bagshaw, BIVDA Board Member, at JAB Associates.

 

ENDS --

Related

BIVDA Press Release - BIVDA Comments on Health and Care White Paper

BIVDA Comments on Health and Care White Paper BIVDA Chief Executive Doris-Ann Williams and Chie...

Read More >

BIVDA Statement - Exemption for Key Workers from COVID App Alerts

Please see the below quote from BIVDA regarding exemptions for key workers regarding COVID-19 a...

Read More >

Press Release - BIVDA welcomes approval of new COVID-19 vaccine

 BIVDA Chief Executive Doris-Ann Williams has welcomed the confirmation of the first COVID-19 v...

Read More >

European Parliament endorses new Regulation on In Vitro Diagnostics

The European Parliament has endorsed the new Regulation on In Vitro Diagnostics (IVDR), a developmen...

Read More >

Member Press Release - Stream Bio collaborates with MIP Diagnostics Ltd. on a rapid diagnostic and mass screening test for COVID-19

PRESS RELEASE22nd April 2020Stream Bio, a company that develops and manufactures a range of transfor...

Read More >

All Party Parliamentary Group to raise the profile of the UK Life Sciences sector

This week marked the relaunch of the All Party Parliamentary Group (APPG) for Life Sciences.

Read More >